Ouvir "(67) Terceira dose da vacina COVID: sim ou não?"
Sinopse do Episódio
Levin EG et al. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N Engl J Med 2021 Oct 6; [e-pub]. (https://doi.org/10.1056/NEJMoa2114583)
Chemaitelly H et al. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N Engl J Med 2021 Oct 6; [e-pub]. (https://doi.org/10.1056/NEJMoa2114114)
Tartof SY et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study. Lancet 2021 Oct 4; [e-pub]. (https://doi.org/10.1016/S0140-6736(21)02183-8)
Chemaitelly H et al. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N Engl J Med 2021 Oct 6; [e-pub]. (https://doi.org/10.1056/NEJMoa2114114)
Tartof SY et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study. Lancet 2021 Oct 4; [e-pub]. (https://doi.org/10.1016/S0140-6736(21)02183-8)
Mais episódios do podcast MGFamiliar
(271) Ciência, Comunidade e Partilha
30/12/2025
(270) O amor que não se anuncia nem se vende
23/12/2025
(267) Café e fibrilhação auricular
02/12/2025
(266) Diabetes tipo 2: uma guideline “viva”
25/11/2025
(263) Batas limpas, mas contaminadas?
04/11/2025
(262) Ensinar a incerteza em Medicina
28/10/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.